Compounds > isoproterenol

isoproterenol and troglitazone

isoproterenol has been researched along with troglitazone in 13 studies

Research

Studies (13)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (7.69)	18.2507
2000's	6 (46.15)	29.6817
2010's	6 (46.15)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S	1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y	1
Asano, M; Hazama, H; Imuta, H; Iwasawa, K; Kawakami, Y; Morita, T; Nakajima, T; Nakamura, F; Okuda, Y; Omata, M; Oonuma, H; Suzuki, J; Suzuki, S	1
Aizawa, Y; Hasebe, N; Kawabe, J; Kikuchi, K; Takehara, N	1
Furuse, Y; Hisatome, I; Ogino, K; Sasaki, N; Shimoyama, M	1
Hashimoto, K; Hori, M; Imahashi, K; Kusuoka, H; Nishimura, T; Terakawa, T; Yoshioka, J	1
Gotoda, T; Harada, K; Iizuka, Y; Ishibashi, S; Kimura, S; Ohashi, K; Okazaki, H; Osuga, J; Shimano, H; Shionoiri, F; Tamura, Y; Tomita, S; Yahagi, N; Yamada, N	1
Fujimoto, N; Matsuo, N; Saikawa, T; Sumiyoshi, H; Yamaguchi, K; Yoshimatsu, H; Yoshioka, H	1

Reviews

1 review(s) available for isoproterenol and troglitazone

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

12 other study(ies) available for isoproterenol and troglitazone

Article	Year
Identifying off-target effects and hidden phenotypes of drugs in human cells. Nature chemical biology, 2006, Volume: 2, Issue:6 Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship	2006
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors	2012
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship	2012
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships. Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16 Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone	2016
Troglitazone inhibits voltage-dependent calcium currents in guinea pig cardiac myocytes. Circulation, 1999, Jun-08, Volume: 99, Issue:22 Topics: Animals; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Calcium Channels, T-Type; Cardiotonic Agents; Chromans; Cyclic AMP; Electric Conductivity; Guinea Pigs; Hypoglycemic Agents; Isoproterenol; Kinetics; Myocardium; Nifedipine; Thiazoles; Thiazolidinediones; Troglitazone; Verapamil	1999
Glucose modifies the cross-talk between insulin and the beta-adrenergic signalling system in vascular smooth muscle cells. Journal of hypertension, 2000, Volume: 18, Issue:10 Topics: Animals; Cells, Cultured; Chromans; Glucose; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Isoproterenol; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Phosphatidylinositol 3-Kinases; Phosphoproteins; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Thiazoles; Thiazolidinediones; Troglitazone	2000
Ca(2+)-sensitizing effect is involved in the positive inotropic effect of troglitazone. British journal of pharmacology, 2001, Volume: 133, Issue:8 Topics: Animals; Calcium; Calcium Channels, L-Type; Cardiotonic Agents; Chromans; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Heart Ventricles; Isoproterenol; Male; Patch-Clamp Techniques; Rats; Rats, Wistar; Ryanodine; Sarcoplasmic Reticulum; Thapsigargin; Thiazoles; Thiazolidinediones; Troglitazone; Ventricular Pressure	2001
Troglitazone enhances glucose uptake induced by alpha-adrenoceptor stimulation via phosphatidylinositol 3-kinase in rat heart. Clinical and experimental pharmacology & physiology, 2001, Volume: 28, Issue:9 Topics: Adenosine Triphosphate; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Androstadienes; Animals; Catecholamines; Chromans; Glucose; Heart; Hemodynamics; Humans; In Vitro Techniques; Insulin; Isoproterenol; Male; Myocardium; Phentolamine; Phenylephrine; Phosphates; Phosphatidylinositol 3-Kinases; Phosphocreatine; Phosphodiesterase Inhibitors; Phosphoinositide-3 Kinase Inhibitors; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Sugar Phosphates; Thiazoles; Thiazolidinediones; Time Factors; Troglitazone; Wortmannin	2001
Lipolysis in the absence of hormone-sensitive lipase: evidence for a common mechanism regulating distinct lipases. Diabetes, 2002, Volume: 51, Issue:12 Topics: Adipocytes; Animals; Cell Differentiation; Chromans; Cyclic AMP-Dependent Protein Kinases; Embryo, Mammalian; Enzyme Inhibitors; Hydrolysis; Isoproterenol; Isoquinolines; Lipase; Lipolysis; Mice; Mice, Knockout; Sterol Esterase; Sulfonamides; Thiazoles; Thiazolidinediones; Tissue Extracts; Triglycerides; Troglitazone; Tumor Necrosis Factor-alpha	2002
Adiponectin is expressed in the brown adipose tissue and surrounding immature tissues in mouse embryos. Biochimica et biophysica acta, 2005, Oct-15, Volume: 1731, Issue:1 Topics: Adiponectin; Adipose Tissue, Brown; Animals; Cells, Cultured; Chromans; Dexamethasone; Gene Expression Regulation, Developmental; Immunohistochemistry; In Situ Hybridization, Fluorescence; Insulin; Isoproterenol; Mice; Rabbits; Receptors, Adiponectin; Receptors, Cell Surface; Reverse Transcriptase Polymerase Chain Reaction; Thiazolidinediones; Triiodothyronine; Troglitazone	2005